Other languages Eli Lilly and Company Wiener Boerse

Equities

LLYC

US5324571083

End-of-day quote Wiener Boerse Other stock markets 03:30:00 28/06/2024 am IST			5-day change	1st Jan Change
851 ^EUR	+1.01%		-.--%	+61.17%

04/07	ETF of the week: Investing in strong trends with the momentum theme
03/07	Health Stocks Slip in Risk-On Trade -- Health Care Roundup	DJ

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Pacientes con diabetes que toman GLP-1 en lugar de insulina tienen menor riesgo de cáncer: estudio	05/07
ETF der Woche: Starke Trends mit Momentum	05/07
L'ETF della settimana: investire in trend forti con il tema del momentum	05/07
ETF van de week: beleggen in sterke trends met de momentumfactor	05/07
ETF de la semana: Invertir en Europa fuera de Francia para evitar el riesgo político	04/07
ETF de la semaine : Investir sur les tendances fortes avec la thématique du momentum	04/07
Stocks to watch as Biden and Trump vie for presidency	03/07
Stocks Edge Up Pre-Bell Ahead of Several Key Economic Reports; Asia, Europe Rise	03/07
Social Buzz: Wallstreetbets Stocks Mixed Pre-Bell Wednesday; Tesla to Advance, Reddit to Decline	03/07
Eli Lilly : Kisinla approuvé par la FDA contre Alzheimer	03/07
En Direct des Marchés : TotalEnergies, Sanofi, Engie, LVMH, Eurofins Scientific, Eli Lilly, Apple...	03/07
AVIS D'ANALYSTES DU JOUR : L'Oréal, Air Liquide, ASM International, Air France-KLM, Pernod Ricard, Forvia...	03/07
On a dit pas si vite !	03/07
OPINIONI DEGLI ANALISTI DEL GIORNO : Eni, Finecobank, Saes Getters, Stellantis, Amadeus, L'Oréal, Cellnex, Barclays, Eni, Endesa, Nordex, ASM International,...	03/07
OPINIONES DE LOS ANALISTAS DEL DÍA : Aena, Amadeus, Naturgy, Mapfre, L'Oréal, Cellnex, Barclays, Eni , Endesa, Nordex, ASM International,...	03/07
Borsa di Italia: Avevamo detto non così in fretta!	03/07
Bolsa de Madrid: Dijimos ¡no tan rápido!	03/07
La FDA aprueba el medicamento donanemab de Eli Lilly contra el Alzheimer	03/07
USA: feu vert au traitement d'Eli Lilly contre la maladie d'Alzheimer	03/07
Reguladores estadounidenses aprueban el medicamento de Eli Lilly contra el Alzheimer	03/07

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

David Ricks, CEO of Eli Lilly: A market of over a billion people

March 13, 2024 at 12:17 am IST